
    
      Screening period (4 weeks) + Randomized Treatment Period (16 weeks) + Post-Treatment Period
      (16 weeks) = 36 weeks.

      To ensure at least 28 participants with co-morbid asthma needed for subgroup analysis,
      recruitment of NP participants without co-morbid asthma would stop when approximately 28
      participants without asthma were randomized.
    
  